Cargando…

Editorial: Decoding checkpoint inhibitor-induced endocrinopathies

Detalles Bibliográficos
Autores principales:	Burnett, Deborah L., Barnet, Megan B., Samaras, Katherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372577/ https://www.ncbi.nlm.nih.gov/pubmed/35966058 http://dx.doi.org/10.3389/fendo.2022.987648

Ejemplares similares

Editorial: Decoding checkpoint inhibitor-induced immune-related adverse events, volume II
por: Burnett, Deborah L., et al.
Publicado: (2023)

Immune Checkpoint Inhibitor-related Endocrinopathies
por: Lu, Difei, et al.
Publicado: (2022)

Immune checkpoint inhibitor-induced endocrinopathies: a possible indicator of improved survival
por: Ornelas, Mariana, et al.
Publicado: (2023)

MON-365 Immune Checkpoint Inhibitors: Endocrinopathies and Severe Electrolyte Abnormalities
por: El Mais, Rania, et al.
Publicado: (2019)

Endocrinopathies Associated with Immune Checkpoint Inhibitor Cancer Treatment: A Review
por: Okura, Naoko, et al.
Publicado: (2020)

Pembrolizumab: An Immunotherapeutic Agent Causing Endocrinopathies
por: Chaudry, Abdul, et al.
Publicado: (2020)

Celiac Disease and the Autoimmune Web of Endocrinopathies
por: Sange, Ibrahim, et al.
Publicado: (2020)

Editorial: Women in endocrinology 2021
por: Perks, Claire M., et al.
Publicado: (2022)

Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones
por: Arefhosseini, Sara, et al.
Publicado: (2022)

Combination immune checkpoint inhibitor therapy nivolumab and ipilimumab associated with multiple endocrinopathies
por: Gunawan, Florence, et al.
Publicado: (2018)

Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment
por: Shalit, Almog, et al.
Publicado: (2023)

SAT443 Prevalence Of Immune Checkpoint Inhibitor-related Endocrinopathies In Patients With Cancers
por: Pittampalli, Shanti, et al.
Publicado: (2023)

Insights Into the Host Contribution of Endocrine Associated Immune-Related Adverse Events to Immune Checkpoint Inhibition Therapy
por: Chye, Adrian, et al.
Publicado: (2022)

Editorial: Immune checkpoint inhibitors in cancer: balancing the benefits with the side effects?
por: Gomes-Lima, Cristiane J., et al.
Publicado: (2023)

Hypothyroidism and diabetes mellitus – a risky dual gestational endocrinopathy
por: Tirosh, Dan, et al.
Publicado: (2013)

Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports
por: Tan, Meng H., et al.
Publicado: (2019)

Incidence and Phenotypes of Endocrinopathies in Association With Immune Checkpoint Inhibitors: The Experience of Integrated Health Network
por: Mehmood, Hassan, et al.
Publicado: (2021)

Abiraterone-Induced Endocrinopathies
por: Decamps, Scarlett, et al.
Publicado: (2023)

Editorial: With obesity becoming the new normal, what should we do? ‐Volume II
por: Tziomalos, Konstantinos, et al.
Publicado: (2022)

FRI344 Is It Possible To Have Two Endocrinopathies From Checkpoint Inhibitor Therapy At The Same Time?
por: Davis, Adam N, et al.
Publicado: (2023)

Diagnostic criteria and proposed management of immune-related endocrinopathies following immune checkpoint inhibitor therapy for cancer
por: Percik, Ruth, et al.
Publicado: (2023)

TAFRO Syndrome: A Case of Significant Endocrinopathy in a Caucasian Patient
por: Miatech, Jennifer L, et al.
Publicado: (2019)

Coexistence of Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and Pancreatitis
por: Zhang, Amy L., et al.
Publicado: (2021)

Editorial: With Obesity Becoming the New Normal, What Should We Do?
por: Samaras, Katherine, et al.
Publicado: (2019)

Sphingosine 1- Phosphate Lyase Insufficiency Syndrome (SPLIS); A Role in Multiple Endocrinopathies
por: Wai Kwong, Ruth Ming, et al.
Publicado: (2021)

Isolated adrenocorticotropic hormone deficiency following immune checkpoint inhibitors treatment often occurs in polyglandular endocrinopathies
por: Chen, Hong, et al.
Publicado: (2023)

Thyroid-related adverse events induced by immune checkpoint inhibitors
por: Chera, Alexandra, et al.
Publicado: (2022)

Editorial: Keeping the Body in Mind: Scientific Effort in Advocating the Best Outcomes for People Living With Severe Mental Illness
por: Samaras, Katherine, et al.
Publicado: (2022)

Multiple endocrinopathies, hypercalcaemia and pancreatitis following combined immune checkpoint inhibitor use- case report and review of literature
por: Newman, Christine, et al.
Publicado: (2021)

Endocrinopathies in celiac disease: when the endocrinologist sees what is invisible to the gastroenterologist
por: Khater, Dooa
Publicado: (2018)

Immunotherapy-induced endocrinopathies: assessment, management and monitoring
por: Nogueira, Edson, et al.
Publicado: (2019)

Editorial: Decoding the Fetal Circadian System and Its Role in Adult Sickness and Health: Melatonin, a Dark History
por: Torres-Farfan, Claudia, et al.
Publicado: (2020)

Immune checkpoint inhibitor-induced hypothyroidism predicts treatment response in Japanese subjects
por: Iwamoto, Yuichiro, et al.
Publicado: (2023)

Endocrinopathies and Male Infertility
por: Sengupta, Pallav, et al.
Publicado: (2021)

Grand Challenge: How Do We Dodge the Obesity Armageddon?
por: Samaras, Katherine
Publicado: (2016)

Endocrine side effects of immune checkpoint inhibitors
por: Cardona, Zulma, et al.
Publicado: (2023)

Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task
por: Barnabei, Agnese, et al.
Publicado: (2022)

Endocrine effects of Fukushima: Radiation-induced endocrinopathy
por: Niazi, Asfandyar Khan, et al.
Publicado: (2011)

SAT-414 A Single Center Retrospective Analysis and Review of Endocrinopathies from Immune Checkpoint Inhibitors Between 2007 and 2017
por: Shariff, Afreen Idris, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor-Induced Diabetic Ketoacidosis: A Report of Four Cases and Literature Review
por: Hong, A Ram, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f1acfresco7le5p1c4i3bnbp63